Semaglutide prescribing for CVD risk ‘not core GP work’, warns BMA

GPs should not prescribe semaglutide for CVD risk reduction unless formally commissioned and funded to do so, BMA guidance warns.

Source: GP Online 2014 News RSS Feed — Read the full story